ClinicalTrials.Veeva

Menu

Park Rx and Physical Activity Among Low-income Children (ParkRx)

Kaiser Permanente logo

Kaiser Permanente

Status

Active, not recruiting

Conditions

Physical Activity
Mental Health Wellness 1

Treatments

Behavioral: Park Rx

Study type

Interventional

Funder types

Other

Identifiers

NCT04114734
R01HL147574

Details and patient eligibility

About

This study is a randomized controlled trial to evaluate ParkRx, a clinic-based counseling intervention in which health care providers prescribe park visits at a specific frequency, duration, and includes instructions for physical activity in the parks. We will assess whether prescribing visits to specific parks changes physical activity levels and improves health and mental health outcomes among low-income pediatric patients.

Full description

Park prescriptions are formal clinical encouragements for patients to engage in more physical activity outdoors. From the beginning, ParkRx has been perceived as a common-sense solution to physical inactivity and to increasing the time children might be spending outdoors in nature. In spite of a lack of rigorous evidence that it is effective, the ParkRx concept is currently being widely disseminated and has been embraced by multiple national organizations. Unity Health, a federally qualified community health center in Washington, DC, is currently implementing park prescriptions for its largely low-income and minority population, a group at high risk of chronic diseases, physical inactivity and obesity. In partnership with Unity Health, we propose to conduct a randomized controlled trial (RCT) to prospectively evaluate Park Rx's impact on physical activity, as well as other secondary health outcomes in pediatric patients. Our specific aims are: 1) to test whether Park Rx will increase park visits and accelerometry-measured physical activity among children; 2) to identify any biological impacts of Park Rx on health, including impact on hypercholesterolemia, hypertriglyceridemia, HbA1C, overweight and obesity, for those patients with relevant diagnoses; 3) to explore impacts on mental health, including stress and measures of cognitive functioning; and 4) to determine whether there are age and gender differences in adherence to and impact of Park Rx. The results of this study will quantify the effectiveness of Park Rx and inform its future dissemination.

Enrollment

500 estimated patients

Sex

All

Ages

6 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ages >6 and <16 with one or more diagnoses of chronic conditions that usually require two or more routine health care provider visits per year.
  • ADHD, or
  • Overweight or obesity, or
  • hypertriglyceridemia or
  • hypercholesterolemia, or
  • pre-diabetes or
  • Type 2 diabetes. AND
  • Likely to live in the Washington DC area in the next 2 years.

Exclusion criteria

  • Individuals who have previously been given a park prescription

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

500 participants in 2 patient groups

Park Rx
Experimental group
Description:
Participants will be given a park prescription as part of their treatment plan
Treatment:
Behavioral: Park Rx
No Park Rx
No Intervention group
Description:
Usual care only

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems